Epigenetic Cancer Therapy

— —

Steven Gray (Senior Clinical Scientist and Adjunct Assistant Professor, Thoracic Oncology Research Group, Trinity Centre for Health Sciences, St. James's Hospital, Dublin, Ireland)

Epigenetic Cancer Therapy

Steven Gray (Senior Clinical Scientist and Adjunct Assistant Professor, Thoracic Oncology Research Group, Trinity Centre for Health Sciences, St. James's Hospital, Dublin, Ireland)

$152.95

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Academic Press Inc
16 July 2015

Cytology; Oncology

Series: Translational Epigenetics

Epigenetic Cancer Therapy unites issues central to a translational audience actively seeking to understand the topic. It is ideal for cancer specialists, including oncologists and clinicians, but also provides valuable information for researchers, academics, students, governments, and decision-makers in the healthcare sector.

The text covers the basic background of the epigenome, aberrant epigenetics, and its potential as a target for cancer therapy, and includes individual chapters on the state of epigenome knowledge in specific cancers (including lung, breast, prostate, liver).

The book encompasses both large-scale intergovernmental initiatives as well as recent findings across cancer stem cells, rational drug design, clinical trials, and chemopreventative strategies. As a whole, the work articulates and raises the profile of epigenetics as a therapeutic option in the future management of cancer.

Edited by: Steven Gray (Senior Clinical Scientist and Adjunct Assistant Professor Thoracic Oncology Research Group Trinity Centre for Health Sciences St. James's Hospital Dublin Ireland)
Imprint: Academic Press Inc
Country of Publication: United States
Dimensions: Height: 234mm, Width: 191mm, Spine: 43mm
Weight: 1.720kg
ISBN: 9780128002063
ISBN 10: 0128002069
Series: Translational Epigenetics
Pages: 748
Publication Date: 16 July 2015
Audience: Professional and scholarly , Undergraduate
Replaced By: 9780323913676
Format: Hardback
Publisher's Status: Active

1. Introduction 2. DNA Methylation & Hydroxymethylation in Cancer 3. Writers, Readers, and Erasers of Epigenetic Marks 4. MicroRNAs and Cancer 5. Long Noncoding RNAs (lncRNAs) and Cancer 6. Ribosomal RNA Methylation and Cancer 7. Mining the Epigenetic Landscape: Surface Mining or Deep Underground 8. Development of Epigenetic Targeted Therapies in Hematological Malignancies: From Serendipity to Synthetic Lethality 9. Epigenetic Therapy in Lung Cancer and Mesothelioma 10. Breast Cancer Epigenetics 11. Therapeutic Applications of the Prostate Cancer Epigenome 12. Liver Cancer (Hepatocellular Carcinoma) 13. Neuroblastoma 14. The Epigenetics of Medulloblastoma 15. Clinical Significance of Epigenetic Alterations in Glioblastoma 16. Esophageal Cancer 17. Nasopharyngeal Cancer 18. Nutritional Epigenetic Inhibitors in the Field of Cancer: New Avenues for Chemopreventive Approaches 19. Emerging Epigenetic Therapies – Lysine Methyltransferase/PRC Complex Inhibitors 20. Inhibitors of Jumonji C Domain Histone Demethylases 21. Emerging Epigenetic Therapies – Lysine Acetyltransferase Inhibitors 22. Emerging Epigenetic Therapies – Bromodomain Ligands 23. Clinical Trials 24. Genetic Intratumor Heterogeneity 25. Epigenetics Underpinning DNA Damage repair 26. Epigenetics of Cisplatin Resistance 27. Therapeutically Targeting Epigenetic Regulation of Cancer Stem Cells 28. Personalized Therapy – Chemosensitivity Testing 29. Personalized Therapy - Epigenetic Profiling as Predictors of Prognosis and Response

Steven Gray is a Senior Clinical Scientist and Adjunct Assistant Professor in the Thoracic Oncology Research Group, Trinity Centre for Health Sciences at St. James's Hospital, Dublin, Ireland.

Reviews for Epigenetic Cancer Therapy

...a helpful reference for researchers and medical professionals interested in epigenetics...contains many resources that may be useful for readers or guide them to technologies and areas of interest quickly. Score: 84 - 3 Stars --Doody's, Epigenetic Cancer Therapy